Scientific cooperation between VRA and EUROVisco: A new step forward in musculoskeletal health care

The ceremony was attended by Dr. Thierry Conrozier - President of EUROVisco; Associate Professor, Dr. Nguyen Thi Ngoc Lan - President of VRA; Associate Professor, Dr. Vu Dinh Hung - Vice President of VRA; Associate Professor, Dr. Nguyen Dinh Khoa - Vice President of VRA and some members of the Executive Committee of the Vietnam Rheumatology Association, Ms. Pham Thi Quyen - Director of Omniarch Healthcare Vietnam Joint Stock Company - representative of the sponsor of the Signing Ceremony.

Representatives of EUROVisco, VRA Executive Board and Omniarch Healthcare Vietnam Board of Directors attended the Signing Ceremony

Vietnam Rheumatology Association (VRA) is the leading professional organization in the field of musculoskeletal system, established in 1992. With more than 450 members nationwide and 4 regional branches, VRA brings together a team of experienced doctors, nurses and researchers. The Association is always a pioneer in training, scientific research and international cooperation, aiming to improve the quality of treatment and care for musculoskeletal patients in Vietnam.

During the meeting, the two sides had in-depth discussions on potential cooperation opportunities and long-term strategic orientations, focusing on research, training and professional development in the field of musculoskeletal system. This signing opens a period of close cooperation, aiming to improve the quality of treatment and promote the application of advanced therapies, especially synovial fluid supplementation therapy in Vietnam.

Associate Professor, Dr. Nguyen Thi Ngoc Lan – President of VRA expressed her belief that the cooperation between VRA and EUROVisco will open up many opportunities for doctors in Vietnam to access modern treatments, while enhancing research capabilities, academic exchange and improving professional capacity in the field of musculoskeletal system. VRA is committed to accompanying EUROVisco in the spirit of sharing, sustainable and effective cooperation – all for the benefit of patients.

Speaking at the event, Dr. Thierry Conrozier expressed EUROVisco’s joy and commitment to accompanying VRA. He affirmed that the organization will actively support knowledge transfer, in-depth training and sharing scientific research achievements to contribute to improving treatment capacity and patient care efficiency.

The signing ceremony between VRA and EUROVisco was sponsored by Omniarch Healthcare Vietnam Joint Stock Company. Ms. Pham Thi Quyen - Director of Omniarch Healthcare Vietnam Joint Stock Company shared that this is a great honor for the company: “We are proud to be a bridge between prestigious medical organizations at home and abroad. The cooperation between EUROVisco and VRA not only opens up opportunities to improve the quality of musculoskeletal treatment, but also promotes research and professional exchange. Omniarch Healthcare Vietnam is committed to continuing to accompany and support cooperation initiatives to achieve practical achievements, contributing to the development of the Vietnamese healthcare sector.”

Associate Professor, Dr. Nguyen Thi Ngoc Lan - Dr. Thierry Conrozier - Ms. Pham Thi Quyen signed a cooperation agreement

The cooperation agreement between VRA and EUROVisco is expected to become a solid foundation to promote international cooperation, actively contributing to the development of the musculoskeletal profession in Vietnam.

PRODUCT LIST OF OMNIARCH HEALTHCARE VIETNAM

- HAPPYCROSS®: Advanced intra-articular injection product (generation II biological joint fluid), combining cross-linked Hyaluronic Acid and Mannitol, applying exclusive IPN® technology from France, effectively relieves pain and lasts up to 12 months.

- HAPPYVISC®: Generation II biological joint fluid combines Hyaluronic Acid with Mannitol, supports pain relief, anti-inflammation and improves joint function in the treatment of osteoarthritis.

- CURADOL MED EMULGEL: Advanced pain relief gel with exclusive formula from natural ingredients and Emulgel technology combined with Phytosome, penetrates quickly, brings a pleasant feeling, helps to reduce pain and inflammation immediately, maintains long-lasting effectiveness.

- SYNART (Hyaluronic Acid 80mg/4ml and 30mg/2ml): Intra-articular injection product combined with ultra-pure Hyaluronic Acid helps reduce inflammation, relieve pain quickly and improve mobility.

Vietnam.vn